HOME   |    PDF   |   


Title

Cutaneous adverse drug reactions: A prospective observational study at a tertiary care hospital in Central India

 

Authors

Sudhir Kumar Jain1, Pawan Kumar Maurya2, Balvir Singh3* & Sourabh Jain4

 

Affiliation

1Department of Pharmacology, ABVGMC Vidisha, Madhya Pradesh, India; 2Department of Pharmacology, Shyam Shah Medical College, Rewa, Madhya Pradesh, India; 3Department of Pharmacology, Government Medical College, Satna, Madhya Pradesh, India; 4Department of Dermatology, ABVGMC Vidisha, Madhya Pradesh, India; *Corresponding author

 

Email

Sudhir Kumar Jain - E-mail: sudhirgmc2001@gmail.com
Pawan Kumar Maurya - E-mail: maurya.pg@gmail.com
Balvir Singh - E-mail: balvir427@gmail.com
Sourabh Jain - E-mail: sourabh.kem@gmail.com

 

Article Type

Research Article

 

Date

Received November 15, 2025; Revised December 15, 2025; Accepted December 15, 2025, Published December 15, 2025

 

Abstract

Cutaneous adverse drug reactions (CADRs) are a common and significant concern, arising from both immunological and non-immunological mechanisms. Therefore, it is of interest to identify the incidence, patterns and drug associations of CADRs at a tertiary care hospital in Vidisha, Madhya Pradesh. A total of 56 cases were observed with fixed drug eruptions (FDEs) caused by NSAIDs being the most frequent. The findings highlight the prevalent role of self-medication and the need for strict regulations, with improved pharmacovigilance to mitigate these adverse reactions.

 

Keywords

Cutaneous adverse drug reactions, fixed drug eruption, pharmacovigilance, NSAIDs, topical steroids

 

Citation

Jain et al. Bioinformation 21(12): 5046-5049 (2025)

 

Edited by

Ritik Kashwani

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.